PFSA
Profusa, Inc. Common StockNASDAQHealthcare$0.76+30.98%ClosedMarket Cap: $422,048
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.02
P/S
0.00
EV/EBITDA
-0.62
DCF Value
$-120.22
FCF Yield
-1128.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
89.6%
ROA
-957.4%
ROIC
194.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $0.00 | NaN% | $-21.7M | $-22.2M | $-52.50 | — |
| Q2 2025 | $0.00 | NaN% | $-967.1K | $-8.2M | $-18.75 | — |
| Q1 2025 | $0.00 | NaN% | $-1.4M | $-2.7M | $-6.21 | — |
| Q4 2024 | $0.00 | NaN% | $-309.8K | $-7.6M | $-96.75 | — |
| FY 2024 | $0.00 | NaN% | $-4.5M | $-9.2M | $-21.00 | — |
| Q3 2024 | $0.00 | NaN% | $-1.1M | $-2.5M | $-96.75 | — |
| Q2 2024 | $0.00 | NaN% | $-253.1K | $-397.5K | $-0.91 | — |
| Q1 2024 | $0.00 | NaN% | $-1.3M | $-2.4M | $-5.45 | — |
| Q4 2023 | $0.00 | NaN% | $-460.2K | $236.0K | $2.94 | — |
| FY 2023 | $0.00 | NaN% | $-6.1M | $-10.3M | $-23.25 | — |
| FY 2022 | $0.00 | NaN% | $-11.1M | $-20.2M | $-46.50 | — |
| FY 2021 | $0.00 | NaN% | $-11.7M | $-10.3M | $-23.25 | — |